Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma
Volume 9, Issue 1, January 2020 .
Source: OncoImmunology - Category: Cancer & Oncology Authors: Alexandra Drakaki Preet K Dhillon Heather Wakelee Stephen Y Chui Jinjoo Shim Matthew Kent Viraj Degaonkar Tien Hoang Virginia McNally Patricia Luhn Ralf Gutzmer Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Corticosteroid Therapy | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Skin Cancer